VXB-251

· Vicebio Australia Proprietary Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VXB-251, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults [Phase 1]